ASN's Mission

ASN leads the fight to prevent, treat, and cure kidney diseases throughout the world by educating health professionals and scientists, advancing research and innovation, communicating new knowledge, and advocating for the highest quality care for patients.

learn more

Contact ASN

1401 H St, NW, Ste 900, Washington, DC 20005


The Latest on Twitter

Kidney Week

Abstract: FR-PO400

CKD Self-Management: Identifying Phenotypes and Associations with Renal and Cardiovascular Outcomes

Session Information

Category: Chronic Kidney Disease (Non-Dialysis)

  • 301 CKD: Risk Factors for Incidence and Progression


  • Schrauben, Sarah J., U Penn, Philadelphia, Pennsylvania, United States
  • Hsu, Jesse Yenchih, U Penn, Philadelphia, Pennsylvania, United States
  • Rosas, Sylvia E., CRIC, Bethesda, Maryland, United States
  • Deo, Rajat, CRIC, Bethesda, Maryland, United States
  • Jaar, Bernard G., CRIC, Bethesda, Maryland, United States
  • Saab, Georges, CRIC, Bethesda, Maryland, United States
  • Lederer, Swati, CRIC, Bethesda, Maryland, United States
  • Chen, Jing, CRIC, Bethesda, Maryland, United States
  • Ricardo, Ana C., CRIC, Bethesda, Maryland, United States
  • Lash, James P., CRIC, Bethesda, Maryland, United States
  • Feldman, Harold I., U Penn, Philadelphia, Pennsylvania, United States
  • Anderson, Amanda Hyre, U Penn, Philadelphia, Pennsylvania, United States

In the effort to slow chronic kidney disease (CKD) progression and its complications, patients need to engage in self-management behaviors. This study evaluated CKD self-management behaviors (CKD-SMB) by identifying patterns of engagement into groups (or phenotypes), and evaluating the association of these phenotypes with renal and cardiovascular outcomes, and death.


Data from the Chronic Renal Insufficiency Cohort (CRIC) Study were analyzed using a clustering technique, latent class analysis (LCA), to identify CKD-SMB phenotypes stratified by diabetes status. The original CRIC cohort (N=3939) was the derivation cohort, and 1,560 participants subsequently recruited served as the validation cohort. LCA was based on the following measures of CKD-SMB: BMI, diet, physical activity, blood pressure, smoking status, and hemoglobin A1c (if diabetic), which were dichotomized into “recommended” and “not recommended”. Cox proportional hazards models calculated hazard ratios (HRs, 95% CI) of phenotypes for CKD progression, atherosclerotic and heart failure (HF) events, and death.


Three CKD-SMB phenotypes were identified separately among diabetics (DM) and non-diabetics (ND) that varied by level of engagement in recommended CKD-SMB, with Phenotype I being the most engaged, Phenotype II moderately engaged, and Phenotype III, the least engaged. In multivariable-adjusted models, Phenotype III was strongly associated with CKD progression, atherosclerotic events, and death among both DM and ND, and Phenotype II was associated with atherosclerotic events in DM and with death in ND (Table).


This study demonstrates there are potentially three CKD-SMB phenotypes that distinguish risk for clinical outcomes. Given the rise of CKD and its complications, CKD-SMB phenotypes could identify high-risk groups and guide management.

Associations (HR, 95% CI) of Clinical Outcomes by CKD-SMB Phenotypes
 Phenotype II-DMPhenotype-II-NDPhenotype III-DMPhenotype III-ND
CKD Progression1.11 (0.91-1.35)1.01 (0.82-1.25)1.82 (1.32-2.52)1.49 (1.06-2.09)
Atherosclerotic Events1.40 (1.04-1.89)1.15 (0.83-1.60)2.54 (1.61-3.99)1.90 (1.18-3.06)
HF Events1.08 (0.84-1.40)1.35 (0.97-1.86)0.90 (0.56-1.45)1.12 (0.66-1.92)
Death1.22 (0.97-1.55)2.80 (1.60-4.89)1.95 (1.35-2.81)4.14 (2.06-8.33)

Phenotype I as referent group.


  • NIDDK Support